JULIA LANGOWSKI: Open Payments
NPI 1184711285 · CLINTON TWP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 9 payments from 7 companies in 2025. Trend: 2023 $495 · 2024 $846 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 1 | $145 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| Dexcom, Inc. | 1 | $35 |
| ABBVIE INC. | 2 | $34 |
Products named: QUTENZA, Wegovy, INGREZZA, JOURNAVX, Dexcom G6 Transmitter, BOTOX.
Industry payments across MI — which companies pay providers there.
